A detailed history of Trust Point Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Trust Point Inc. holds 4,050 shares of LLY stock, worth $3.26 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
4,050
Previous 3,760 7.71%
Holding current value
$3.26 Million
Previous $3.4 Billion 5.4%
% of portfolio
0.27%
Previous 0.27%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$772.14 - $960.02 $223,920 - $278,405
290 Added 7.71%
4,050 $3.59 Billion
Q2 2024

Jul 24, 2024

BUY
$724.87 - $909.04 $17,396 - $21,816
24 Added 0.64%
3,760 $3.4 Billion
Q1 2024

Apr 19, 2024

BUY
$592.2 - $792.28 $30,794 - $41,198
52 Added 1.41%
3,736 $2.91 Billion
Q4 2023

Jan 23, 2024

BUY
$525.19 - $619.13 $1.93 Million - $2.28 Million
3,684 New
3,684 $2.15 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $766B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Trust Point Inc. Portfolio

Follow Trust Point Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Point Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trust Point Inc. with notifications on news.